Pioneering the Future of Neurodegenerative Care
Our Story and Commitment
Keystone Neurogenics was founded to push the boundaries of neurological therapy using cutting-edge biotechnology. Our mission is to deliver next-generation digital and gene-editing solutions that not only treat but delay the onset of debilitating neurodegenerative diseases. Our work is fueled by a passionate leadership team and guided by the goal to bring hope and meaningful progress to patients and families worldwide.
Meet Our Team and Discover Our Mission
Committed to Scientific Excellence and Patient Care
Our leadership team leads with expertise and vision, integrating proprietary AI and gene-editing technologies to develop revolutionary therapies. Join us in advancing hope and clarity for those affected by neurological disorders.